Novartis

BioScrip to Settle False Health Care Claims for $15M
January 17, 2014
BioScrip has agreed to pay $15 million to resolve allegations under the False Claims Act that they received kickbacks from Novartis in exchange for recommending refills to patients, the Department of Justice announced earlier this week. Novartis allegedly provided kickbacks to BioScrip, in the form of patient referrals and in the guise of rebates, in exchange for BioScrip...
False Claims / Whistleblowers
BioScrip, Exjade, False Claims Act, Medicaid, Medicaid Fraud, Medicare Fraud, Novartis, qui tam lawsuit, Whistleblower Act, whistleblower attorneys
Read More
U.S. Files 2nd Complaint Against Novartis Re: Kickbacks to Prescribing Doctors
May 1, 2013
The United States filed a second false claims action against Novartis Pharmaceuticals Corp. alleging that they paid kickbacks to doctors to induce them to prescribe Novartis pharmaceutical products that were reimbursed by federal health care programs, the Justice Department announced last week. The government alleges that from January 2001 through November 2011, Novartis...
False Claims / Whistleblowers
False Claims Act, healthcare fraud, Medicaid Fraud, Medicare Fraud, Novartis, Pharmaceuticals
Read More